Historically we have always managed to bounce off of the $6.70 ish range. We should get enough minor PR's to keep us range bound around $7 until we get some tangible positive update. I don't see us going lower than $6.50 so anything in the mid to high $6's is a good investment/average down imo.
Disagree. I believe we are down below $7 (again) due to tax selling and lack of progress on PT4/5. We haven't signed up any new patients in some time and it's been several months since a new hospital has signed on. At this pace, it will be a few years to get the additional patients the study requires. Why put money under a mattress here when it can be invested in bank stocks (anticipating rising interest rates) or oil stocks (down on their arss) so rebound expected or other bio-techs that have more near term catalysts. I still have a ton of NVIV shares but don't believe we shoot to $15 once the tute is filled. That theory just seems too much a stretch to me.
While I was pleasantly surprised by this morning's PR, I am really hoping that they reveal positive progress being make on patients 4,5. It's fantastic that they are approaching chronic but how will the market react in the short term if that is overshadowed with no positive update on the last few patients? Just throwing it out there. If we get AIS improvements on pt 4 and 5 (or at least improved B&B), clear timelines on the pivotal along with the chronic pursuit then we're really off to the races on the stock price. If we hear that patients 4 and 5 haven't positively responded to the scaffold as of yet, this will cast somewhat of a dark cloud on things imo. We shall see.
PM- I would love to load up on LLTP but all my money is tied up in ABRW. I complained to IR that their stock price keeps going down but they told me they'd send me a 6 pack of delicious microbrew for Christmas so I guess it's all good.